publicações selecionadas
-
artigo académico
-
artigo de revista
- Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma. Cancers. 2021
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics. 2018
- The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma. Oncotarget. 2018
- Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of Neuro-Oncology. 2017
- A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget. 2015
- The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival. Carcinogenesis. 2015
-
documento
- CDH3/P-cadherin expression is associated with aggressiveness of human glioblastoma 2018
- CDH3/P-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights 2018
- Functional impact and prognostic relevance of CDH3/P-cadherin in glioblastoma 2018
- Intracellular autofluorescence: a new biomarker for Glioblastoma Stem Cells 2017
- WNT6 regulation in Glioblastoma: Mechanistic, Functional and Clinical implications 2017
- Intracellular autofluorescence: a new biomarker for Glioblastoma Stem Cells” 2017
- Regulation of WNT6 by HOXA9 in glioblastoma: functional and clinical relevance 2016
- HOXA9-mediated activation of the WNT pathway: functional and clinical relevance in glioblastoma 2015
- HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma 2014
- Regulation of Wnt Signaling by HOXA9 in Glioblastoma: Mechanistic and Prognostic Insights 2014
- WNT6 promoter methylation associates with its expression in glioblastoma 2014